Regenxbio Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning. Thank you all for joining today my name is [Steve] (inaudible) and I'm a member of the JPMorgan Healthcare Investment Banking team.
It is my great pleasure to introduce Ken Mills, President and CEO of REGENXBIO. (Operator Instructions) Ken?
Thank you, [Steve], and good morning, everyone. Thanks to the organizers and JPMorgan for inviting myself and REGENXBIO to present today at the conference. Hope everyone is doing well and is safe in this new year. We'll be providing some forward-looking statements in this presentation. The references to additional information about REGENXBIO that are on file with the SEC can be found on Slide 2 of the accompanying presentation.
But I'm going to start my presentation with Slide 3 and describe REGENXBIO, its mission, our focus, which is patient-focused, seeking to improve the lives through the curative potential of gene therapy as many patients and families as possible. We have multiple ongoing clinical studies at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
